Viewing Study NCT02021318


Ignite Creation Date: 2025-12-25 @ 4:54 AM
Ignite Modification Date: 2026-02-26 @ 12:03 PM
Study NCT ID: NCT02021318
Status: COMPLETED
Last Update Posted: 2024-11-14
First Post: 2013-12-20
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: Roxadustat in the Treatment of Anemia in Chronic Kidney Disease (CKD) Patients, Not on Dialysis, in Comparison to Darbepoetin Alfa
Sponsor: Astellas Pharma Europe B.V.
Organization:

Key Dates - Follows AllAPIJSON File Order

Start Date: 2014-03-12
Start Date Type: ACTUAL
Primary Completion Date: 2018-03-23
Primary Completion Date Type: ACTUAL
Completion Date: 2019-11-06
Completion Date Type: ACTUAL
First Submit Date: 2013-12-20
First Submit QC Date: None
Study First Post Date: 2013-12-27
Study First Post Date Type: ESTIMATED
Results First Submit Date: 2021-03-02
Results First Submit QC Date: None
Results First Post Date: 2021-03-29
Results First Post Date Type: ACTUAL
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: 2019-03-28
Disp First Post Date Type: ACTUAL
Last Update Submit Date: 2024-10-29
Last Update Post Date: 2024-11-14
Last Update Post Date Type: ACTUAL